 | • レポートコード：MRC2102QY11721 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の前立腺がん診断市場について種類別（腫瘍バイオマーカー検査、画像診断、生検、その他）、用途別（55歳以下、55〜75歳、75歳以上）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・前立腺がん診断市場の概要 ・世界の主要地域別前立腺がん診断市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の前立腺がん診断市場規模2015-2026：種類別（腫瘍バイオマーカー検査、画像診断、生検、その他） ・世界の前立腺がん診断市場規模2015-2026：用途別（55歳以下、55〜75歳、75歳以上） ・前立腺がん診断の米国市場規模2015-2020 ・前立腺がん診断のヨーロッパ市場規模2015-2020 ・前立腺がん診断の中国市場規模2015-2020 ・前立腺がん診断の日本市場規模2015-2020 ・前立腺がん診断の東南アジア市場規模2015-2020 ・前立腺がん診断のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・前立腺がん診断の製造コスト分析 ・販売チャネル、流通業者、顧客 ・前立腺がん診断の市場動向・機会・課題 ・調査の結論 |
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.
North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.
Market Analysis and Insights: Global Prostate Cancer Diagnostics Market
The global Prostate Cancer Diagnostics market size is projected to reach US$ 19100 million by 2026, from US$ 12520 million in 2020, at a CAGR of 7.3% during 2021-2026.
Global Prostate Cancer Diagnostics Scope and Market Size
The global Prostate Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Prostate Cancer Diagnostics market is segmented into
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segment by Application, the Prostate Cancer Diagnostics market is segmented into
age < 55
age 55-75
age > 75
The Prostate Cancer Diagnostics market is analysed and market size information is provided by regions (countries). Segment by Application, the Prostate Cancer Diagnostics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis
Prostate Cancer Diagnostics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prostate Cancer Diagnostics business, the date to enter into the Prostate Cancer Diagnostics market, Prostate Cancer Diagnostics product introduction, recent developments, etc.
The major vendors covered:
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
BioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
1 Prostate Cancer Diagnostics Market Overview
1.1 Prostate Cancer Diagnostics Product Scope
1.2 Prostate Cancer Diagnostics Segment by Type
1.2.1 Global Prostate Cancer Diagnostics Sales by Type (2020-2026)
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Prostate Cancer Diagnostics Segment by Application
1.3.1 Global Prostate Cancer Diagnostics Sales Comparison by Application (2020-2026)
1.3.2 age < 55
1.3.3 age 55-75
1.3.4 age > 75
1.4 Prostate Cancer Diagnostics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Prostate Cancer Diagnostics Sales Growth Rate (2015-2026)
1.4.2 Global Prostate Cancer Diagnostics Revenue and Growth Rate (2015-2026)
1.4.3 Global Prostate Cancer Diagnostics Price Trends (2015-2026)
2 Prostate Cancer Diagnostics Estimate and Forecast by Region
2.1 Global Prostate Cancer Diagnostics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Prostate Cancer Diagnostics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
2.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020)
2.3 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Prostate Cancer Diagnostics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Prostate Cancer Diagnostics Estimates and Projections (2015-2026)
2.4.2 Europe Prostate Cancer Diagnostics Estimates and Projections (2015-2026)
2.4.3 China Prostate Cancer Diagnostics Estimates and Projections (2015-2026)
2.4.4 Japan Prostate Cancer Diagnostics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Prostate Cancer Diagnostics Estimates and Projections (2015-2026)
2.4.6 India Prostate Cancer Diagnostics Estimates and Projections (2015-2026)
3 Global Prostate Cancer Diagnostics Competition Landscape by Players
3.1 Global Top Prostate Cancer Diagnostics Players by Sales (2015-2020)
3.2 Global Top Prostate Cancer Diagnostics Players by Revenue (2015-2020)
3.3 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2019)
3.4 Global Prostate Cancer Diagnostics Average Price by Company (2015-2020)
3.5 Manufacturers Prostate Cancer Diagnostics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Prostate Cancer Diagnostics Players (Opinion Leaders)
4 Global Prostate Cancer Diagnostics Market Size by Type
4.1 Global Prostate Cancer Diagnostics Historic Market Review by Type (2015-2020)
4.1.1 Global Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
4.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2015-2020)
4.1.3 Global Prostate Cancer Diagnostics Price by Type (2015-2020)
4.2 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2026)
4.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026)
4.2.3 Global Prostate Cancer Diagnostics Price Forecast by Type (2021-2026)
5 Global Prostate Cancer Diagnostics Market Size by Application
5.1 Global Prostate Cancer Diagnostics Historic Market Review by Application (2015-2020)
5.1.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
5.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2020)
5.1.3 Global Prostate Cancer Diagnostics Price by Application (2015-2020)
5.2 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2026)
5.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026)
5.2.3 Global Prostate Cancer Diagnostics Price Forecast by Application (2021-2026)
6 United States Prostate Cancer Diagnostics Market Facts & Figures
6.1 United States Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
6.2 United States Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
6.3 United States Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
7 Europe Prostate Cancer Diagnostics Market Facts & Figures
7.1 Europe Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
7.2 Europe Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
7.3 Europe Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
8 China Prostate Cancer Diagnostics Market Facts & Figures
8.1 China Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
8.2 China Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
8.3 China Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
9 Japan Prostate Cancer Diagnostics Market Facts & Figures
9.1 Japan Prostate Cancer Diagnostics Sales Market Share by Company (3015-3030)
9.2 Japan Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
9.3 Japan Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
10 Southeast Asia Prostate Cancer Diagnostics Market Facts & Figures
10.1 Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
11 India Prostate Cancer Diagnostics Market Facts & Figures
11.1 India Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
11.2 India Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
11.3 India Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Prostate Cancer Diagnostics Business
12.1 Genomic Health
12.1.1 Genomic Health Corporation Information
12.1.2 Genomic Health Business Overview
12.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Genomic Health Prostate Cancer Diagnostics Products Offered
12.1.5 Genomic Health Recent Development
12.2 Abbott
12.2.1 Abbott Corporation Information
12.2.2 Abbott Business Overview
12.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Prostate Cancer Diagnostics Products Offered
12.2.5 Abbott Recent Development
12.3 OPKO
12.3.1 OPKO Corporation Information
12.3.2 OPKO Business Overview
12.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 OPKO Prostate Cancer Diagnostics Products Offered
12.3.5 OPKO Recent Development
12.4 Siemens Healthcare
12.4.1 Siemens Healthcare Corporation Information
12.4.2 Siemens Healthcare Business Overview
12.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Siemens Healthcare Prostate Cancer Diagnostics Products Offered
12.4.5 Siemens Healthcare Recent Development
12.5 DiaSorin
12.5.1 DiaSorin Corporation Information
12.5.2 DiaSorin Business Overview
12.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 DiaSorin Prostate Cancer Diagnostics Products Offered
12.5.5 DiaSorin Recent Development
12.6 BioMeriux
12.6.1 BioMeriux Corporation Information
12.6.2 BioMeriux Business Overview
12.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BioMeriux Prostate Cancer Diagnostics Products Offered
12.6.5 BioMeriux Recent Development
12.7 Roche
12.7.1 Roche Corporation Information
12.7.2 Roche Business Overview
12.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Roche Prostate Cancer Diagnostics Products Offered
12.7.5 Roche Recent Development
12.8 MDx Health
12.8.1 MDx Health Corporation Information
12.8.2 MDx Health Business Overview
12.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 MDx Health Prostate Cancer Diagnostics Products Offered
12.8.5 MDx Health Recent Development
12.9 Beckman Coulter
12.9.1 Beckman Coulter Corporation Information
12.9.2 Beckman Coulter Business Overview
12.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Beckman Coulter Prostate Cancer Diagnostics Products Offered
12.9.5 Beckman Coulter Recent Development
12.10 Myriad Genetics
12.10.1 Myriad Genetics Corporation Information
12.10.2 Myriad Genetics Business Overview
12.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Myriad Genetics Prostate Cancer Diagnostics Products Offered
12.10.5 Myriad Genetics Recent Development
12.11 Ambry Genetics
12.11.1 Ambry Genetics Corporation Information
12.11.2 Ambry Genetics Business Overview
12.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Ambry Genetics Prostate Cancer Diagnostics Products Offered
12.11.5 Ambry Genetics Recent Development
13 Prostate Cancer Diagnostics Manufacturing Cost Analysis
13.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
13.4 Prostate Cancer Diagnostics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Prostate Cancer Diagnostics Distributors List
14.3 Prostate Cancer Diagnostics Customers
15 Market Dynamics
15.1 Prostate Cancer Diagnostics Market Trends
15.2 Prostate Cancer Diagnostics Opportunities and Drivers
15.3 Prostate Cancer Diagnostics Market Challenges
15.4 Prostate Cancer Diagnostics Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Prostate Cancer Diagnostics Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Prostate Cancer Diagnostics Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Prostate Cancer Diagnostics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Prostate Cancer Diagnostics Sales (K Units) by Region (2015-2020)
Table 5. Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
Table 6. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Prostate Cancer Diagnostics Revenue Share by Region (2015-2020)
Table 8. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Prostate Cancer Diagnostics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Prostate Cancer Diagnostics Revenue Share Forecast by Region (2021-2026)
Table 12. Global Prostate Cancer Diagnostics (K Units) of Key Companies (2015-2020)
Table 13. Global Prostate Cancer Diagnostics Sales Share by Company (2015-2020)
Table 14. Global Prostate Cancer Diagnostics Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Prostate Cancer Diagnostics Revenue Share by Company (2015-2020)
Table 16. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2019)
Table 17. Global Prostate Cancer Diagnostics Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Prostate Cancer Diagnostics Manufacturing Sites and Area Served
Table 19. Manufacturers Prostate Cancer Diagnostics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Prostate Cancer Diagnostics Players
Table 22. Global Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 23. Global Prostate Cancer Diagnostics Sales Share by Type (2015-2020)
Table 24. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Prostate Cancer Diagnostics Price (K Units) by Type (2015-2020)
Table 26. Global Prostate Cancer Diagnostics Sales Share by Type (2021-2026)
Table 27. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Prostate Cancer Diagnostics Revenue Share by Type (2021-2026)
Table 29. Global Prostate Cancer Diagnostics Price (K Units) by Type (2021-2026)
Table 30. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 31. Global Prostate Cancer Diagnostics Sales Share by Application (2015-2020)
Table 32. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Prostate Cancer Diagnostics Price (K Units) by Application (2015-2020)
Table 34. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2021-2026)
Table 35. Global Prostate Cancer Diagnostics Sales Share by Application (2021-2026)
Table 36. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Prostate Cancer Diagnostics Revenue Share by Application (2021-2026)
Table 38. Global Prostate Cancer Diagnostics Price (K Units) by Application (2021-2026)
Table 39. United States Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020)
Table 40. United States Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
Table 41. United States Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 42. United States Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Table 43. United States Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 44. United States Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Table 45. Europe Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020)
Table 46. Europe Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
Table 47. Europe Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 48. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Table 49. Europe Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 50. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Table 51. China Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020)
Table 52. China Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
Table 53. China Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 54. China Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Table 55. China Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 56. China Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Table 57. Japan Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020)
Table 58. Japan Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
Table 59. Japan Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 60. Japan Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Table 61. Japan Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 62. Japan Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Table 69. India Prostate Cancer Diagnostics Sales (K Units) by Company (2015-2020)
Table 70. India Prostate Cancer Diagnostics Sales Market Share by Company (2015-2020)
Table 71. India Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 72. India Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Table 73. India Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 74. India Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Table 75. Genomic Health Corporation Information
Table 76. Genomic Health Description and Business Overview
Table 77. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Genomic Health Prostate Cancer Diagnostics Product
Table 79. Genomic Health Recent Development
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Abbott Prostate Cancer Diagnostics Product
Table 84. Abbott Recent Development
Table 85. OPKO Corporation Information
Table 86. OPKO Description and Business Overview
Table 87. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. OPKO Prostate Cancer Diagnostics Product
Table 89. OPKO Recent Development
Table 90. Siemens Healthcare Corporation Information
Table 91. Siemens Healthcare Description and Business Overview
Table 92. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 94. Siemens Healthcare Recent Development
Table 95. DiaSorin Corporation Information
Table 96. DiaSorin Description and Business Overview
Table 97. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. DiaSorin Prostate Cancer Diagnostics Product
Table 99. DiaSorin Recent Development
Table 100. BioMeriux Corporation Information
Table 101. BioMeriux Description and Business Overview
Table 102. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. BioMeriux Prostate Cancer Diagnostics Product
Table 104. BioMeriux Recent Development
Table 105. Roche Corporation Information
Table 106. Roche Description and Business Overview
Table 107. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Roche Prostate Cancer Diagnostics Product
Table 109. Roche Recent Development
Table 110. MDx Health Corporation Information
Table 111. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. MDx Health Description and Business Overview
Table 113. MDx Health Prostate Cancer Diagnostics Product
Table 114. MDx Health Recent Development
Table 115. Beckman Coulter Corporation Information
Table 116. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Beckman Coulter Description and Business Overview
Table 118. Beckman Coulter Prostate Cancer Diagnostics Product
Table 119. Beckman Coulter Recent Development
Table 120. Myriad Genetics Corporation Information
Table 121. Myriad Genetics Description and Business Overview
Table 122. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Myriad Genetics Prostate Cancer Diagnostics Product
Table 124. Myriad Genetics Recent Development
Table 125. Ambry Genetics Corporation Information
Table 126. Ambry Genetics Description and Business Overview
Table 127. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Ambry Genetics Prostate Cancer Diagnostics Product
Table 129. Ambry Genetics Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Prostate Cancer Diagnostics Distributors List
Table 133. Prostate Cancer Diagnostics Customers List
Table 134. Prostate Cancer Diagnostics Market Key Trends
Table 135. Prostate Cancer Diagnostics Key Opportunities and Drivers
Table 136. Prostate Cancer Diagnostics Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Prostate Cancer Diagnostics Market Share by Application in 2020 & 2026
Figure 6. age < 55 Examples
Figure 7. age 55-75 Examples
Figure 8. age > 75 Examples
Figure 9. Global Prostate Cancer Diagnostics Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Prostate Cancer Diagnostics Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Prostate Cancer Diagnostics Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Prostate Cancer Diagnostics Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Prostate Cancer Diagnostics Players Market Share by Revenue in Prostate Cancer Diagnostics 2015 & 2019
Figure 27. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Prostate Cancer Diagnostics Revenue Share by Type (2015-2020)
Figure 29. Global Prostate Cancer Diagnostics Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Prostate Cancer Diagnostics Revenue Share by Application (2015-2020)
Figure 31. Global Prostate Cancer Diagnostics Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Prostate Cancer Diagnostics Sales Market Share by Type in 2019
Figure 33. United States Prostate Cancer Diagnostics Sales Market Share by Type in 2019
Figure 34. Europe Prostate Cancer Diagnostics Sales Market Share by Company in 2019
Figure 35. Europe Prostate Cancer Diagnostics Sales Market Share by Type in 2019
Figure 36. Europe Prostate Cancer Diagnostics Sales Market Share by Application in 2019
Figure 37. China Prostate Cancer Diagnostics Sales Market Share by Company in 2019
Figure 38. China Prostate Cancer Diagnostics Sales Market Share by Type in 2019
Figure 39. China Prostate Cancer Diagnostics Sales Market Share by Application in 2019
Figure 40. Japan Prostate Cancer Diagnostics Sales Market Share by Company in 2019
Figure 41. Japan Prostate Cancer Diagnostics Sales Market Share by Type in 2019
Figure 42. Japan Prostate Cancer Diagnostics Sales Market Share by Application in 2019
Figure 43. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Company in 2019
Figure 44. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type in 2019
Figure 45. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application in 2019
Figure 46. India Prostate Cancer Diagnostics Sales Market Share by Company in 2019
Figure 47. India Prostate Cancer Diagnostics Sales Market Share by Type in 2019
Figure 48. India Prostate Cancer Diagnostics Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Prostate Cancer Diagnostics
Figure 51. Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure 52. Prostate Cancer Diagnostics Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
がん診断装置の世界市場レポート2020 Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical compan…- がん画像システムの世界市場レポート2020 Market Analysis and Insights: Global Cancer Imaging System Market The global Cancer Imaging System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cancer Imaging System Scope and Market Size The global Cancer Imaging Sy…
- 前立腺生検装置の世界市場レポート2020 Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer. Prostate biopsy samples can be collected in different ways. Your prostate biopsy may involve: 1. Passing the needle through the …
- 前立腺生検針の世界市場レポート2020 Market Analysis and Insights: Global Prostate Biopsy Needle Market The global Prostate Biopsy Needle market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Prostate Biopsy Needle Scope and Market Size The global Prostate Biops…
- 次世代がん診断装置の世界市場レポート2020 Market Analysis and Insights: Global Next Generation Cancer Diagnostic Devices Market The global Next Generation Cancer Diagnostic Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Next Generation Cancer Diagnosti…